Saturday, November 18, 2023

 

Scientists move closer to long-theorized ultraprecise nuclear clock


Fundamental physics experiments need timekeeping devices more exact than the standard atomic clock


Peer-Reviewed Publication

DOE/ARGONNE NATIONAL LABORATORY



New light sources have made it possible to explore new methods of powering a nuclear clock. Work led by Argonne researchers now points the way toward this once-theoretical timepiece.

For decades, the standard reference tool for ultraprecise timekeeping has been the atomic clock. Scientists have known that an even more precise and reliable timepiece was possible, but technical limitations kept it only a theoretical prospect.

Now, researchers from the U.S. Department of Energy’s (DOE) Argonne National Laboratory, Texas A&M University and several European institutions are turning theory into practice. The team has used X-ray beams to excite a long-lived nuclear state in scandium-45, an element used in aerospace components and sports equipment. The work was published in Nature and represents the culmination of a long scientific quest for lead investigator Yuri Shvyd’ko of Argonne.

An atomic clock and a nuclear clock might sound like basically the same thing, but there are differences in how they work. Atomic clocks oscillate based on the quantum transition which occurs when an electron inside an atom is transferred from one energy level to another at a very precise frequency. Accurate to about one second in 300 million years, this is more than enough to serve as the primary time standard for GPS navigation, computer networks and most other human activities.

“For purposes that demand such precision, including the study of certain aspects of relativity, gravitational theory and other physical phenomena such as dark matter, the nuclear clock is the ultimate timepiece.” — Olga Kocharovskaya, Texas A&M University

A nuclear clock is based on the natural oscillation of the much smaller nucleus at the very center of an atom, rather than the large cloud of electrons swirling around it. Nuclear clocks are much more immune to disturbances such as temperature changes or electromagnetic fields that can spoil the remarkable precision of an atomic clock. This offers even higher precision in a much more stable form.

“For purposes that demand such precision, including the study of certain aspects of relativity, gravitational theory and other physical phenomena such as dark matter, the nuclear clock is the ultimate timepiece,” said Olga Kocharovskaya of Texas A&M University, a co-author on the paper.

Until now, one of the stumbling blocks to the realization of a true nuclear clock has been that existing X-ray sources weren’t quite able to provide the necessary kick to start a nucleus oscillating and then detect it. Another has been the identification of a good candidate nucleus. The most promising has generally been considered to be thorium-229.

Scandium-45 has long been considered another promising candidate, ever since Argonne scientists discovered the comparatively long life of its excited state in 1964. With no way to excite the oscillations, however, the material dropped off the radar for decades. In 1990, Shvyd’ko — then working at an institute in Moscow — and his colleagues published a paper showing that newly emerging accelerator-based X-ray light sources could be used to power the oscillations.

“In that paper, we showed that light sources could be used,” Shvyd’ko said. ​“Despite the fact that they are broadband sources, they can be used to excite and drive this resonance, and one could also measure the very narrow width of the resonance.

One such light source is the Advanced Photon Source (APS), a DOE Office of Science user facility at Argonne, which saw its first light in 1995. But even the APS X-ray beams do not have the intensity required to accomplish the task. It took the recent advent of advanced X-ray free electron laser (XFEL) sources, such as the European XFEL facility (EuXFEL) in Hamburg, Germany, to turn theory into reality.

“Finding the nuclear resonance within scandium-45 demanded an extremely high-intensity source of X-ray beams along with a specially designed protocol for a very low-noise background detection. Both of these were realized at EuXFEL,” said Ralf Röhlsberger of the Helmholtz Institute Jena in Germany, a co-author on the paper

Finding the right resonance energy required a scrupulous tuning of the X-ray energy until the telltale photons from nuclear decay — which act as a signature of the resonance — were found.

“We confirmed the detection of approximately 93 nuclear decay events with a high level of confidence,” said Peifan Liu of Argonne, a co-author on the paper. ​“Simultaneously, the energy of the resonance was determined precisely, with an accuracy 250 times higher than that previously known.”

Taken together, these results open new prospects for revolutionizing highly sensitive probes of natural properties like gravity and enabling fundamental physics tests that rely on the measurement of time or frequency with utmost precision, researchers said

The success of this experiment is a significant milestone in realizing the long-held potential of a scandium-45 nuclear clock. But this is only the beginning of a long journey, one that will require more breakthroughs in detailed studies of the resonance and the development of even more advanced X-ray sources.

About the Advanced Photon Source

The U. S. Department of Energy Office of Science’s Advanced Photon Source (APS) at Argonne National Laboratory is one of the world’s most productive X-ray light source facilities. The APS provides high-brightness X-ray beams to a diverse community of researchers in materials science, chemistry, condensed matter physics, the life and environmental sciences, and applied research. These X-rays are ideally suited for explorations of materials and biological structures; elemental distribution; chemical, magnetic, electronic states; and a wide range of technologically important engineering systems from batteries to fuel injector sprays, all of which are the foundations of our nation’s economic, technological, and physical well-being. Each year, more than 5,000 researchers use the APS to produce over 2,000 publications detailing impactful discoveries, and solve more vital biological protein structures than users of any other X-ray light source research facility. APS scientists and engineers innovate technology that is at the heart of advancing accelerator and light-source operations. This includes the insertion devices that produce extreme-brightness X-rays prized by researchers, lenses that focus the X-rays down to a few nanometers, instrumentation that maximizes the way the X-rays interact with samples being studied, and software that gathers and manages the massive quantity of data resulting from discovery research at the APS.

This research used resources of the Advanced Photon Source, a U.S. DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://​ener​gy​.gov/​s​c​ience.

 YOU ARE NOT A LUDDITE

Sticking with old technology can be a strategic move



Peer-Reviewed Publication

STRATEGIC MANAGEMENT SOCIETY




Technological innovation — especially disruptive innovation — is often heralded as the best strategy for a company. But new research published in Strategic Management Journal found that as competitors adopt new technology in some markets, firms that stick with the old technology may experience an initial decline before actually rebounding and even reaching new heights. While the rise of a discontinuous technology does pose a substitute threat to the old technology, it also further exposes niche segments where companies can gain a foothold with customers who favor the old technology.

The analysis by Xu Li, a professor at the London School of Economics and Political Science, used archival data from the traditional Chinese medicine industry in China during the 1990s. In his interviews with managers in the field, he found that some chose not to innovate along with their competitors. In many cases, Li found these companies were performing well, if not sometimes better, by not making changes. Inspired by these conversations, Li chose to study under what conditions a firm may benefit from not innovating.

Li found some prior research on why companies would stick with older technology, but none explored why — during times of disruptive change in the market — sometimes firms are able to survive and even perform better within a small niche with old technology. What Li’s paper showed was that adhering to the old technology can, in some cases, be an effective strategy that ultimately improves firm performance.

The data showed a U-curve effect for traditional Chinese medicine firms that chose not to adopt new technology: The decline in performance began as a few competitors started launching a new technology, but later recovered and reached new heights as most competitors had adopted the new technology and exited the old technology market. But a lack of competition within the niche group of consumers who prefer older technology essentially gave these firms a monopoly within a smaller market as fewer competitors remained.

“Even though the new technology is often superior in terms of functionality, it doesn’t mean that every single customer or customer segment will be willing to move to the new technology,” Li says. “It’s important to understand what customers like about your product. We tend to assume that if a firm introduces something new, then customers must appreciate the new thing or the newness of the offering. But that’s not always true. The emergence of new technology can actually reveal people’s preference for something older.”

The research also refutes the idea that when the market is small, a company won’t perform better — but that depends on how many firms are still serving this niche. If only a few firms are left to serve this market, a company has far more power to charge higher prices among loyal customers with few other options.

“When you see a firm that is not actively innovating, we tend to believe the firm must be either incapable or is suffering — it’s always a bit of a negative tone,” Li says. “Sometimes staying with old technology might actually be a strategic choice, because by doing so it might also lead to better performance.”

The Strategic Management Journal, published by the Strategic Management Society, is the world’s leading mass impact journal for research in strategic management.

 

Experts urge reforms at FDA to rebuild trust


Five factors proposed in Hastings Center Special Report


Peer-Reviewed Publication

THE HASTINGS CENTER




In a new report aimed at rebuilding trust in health care and science, leading experts urge the U.S. Food and Drug Administration to adopt five reforms to rebuild public trust amid controversies around vaccine approvals.

In "Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines," Leah Z. Rand, Daniel P. Carpenter, Aaron Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman recommend the FDA consider five major factors to maintain its trustworthiness as an organization and to enhance public trust in its decisions, including:

  • Making decisions that are consistent with its existing rules
  • Employing expert decision-makers
  • Avoiding problematic interference from politicians
  • Staying connected to public preference
  • Providing transparency in its decision-making process

“The pandemic revealed that the FDA must navigate political interests, and its responsibilities to be accountable and make evidence-informed decisions, with missteps leading to a lack of trust,” said Leah Rand, one of the authors who is a research scientist at Brigham and Women’s Hospital and Harvard Medical School.

The authors state that "these five conditions, both procedural and substantive, are necessary for FDA trustworthiness, particularly when it conducts reviews and issues approvals, given that it is a government agency subject to political control."

The essay is part of a new Hastings Center special report, Time to RebuildEssays on Trust in Health Care and Science, which explores the causes of the decline in trust in health and science and proposes pathways to rebuild in a series of articles.

"The scientific community must rebuild trust, and the authors of this article have given us five clear conditions for the FDA to regain the confidence of the American public," said Gregory E. Kaebnick, a senior research scholar at The Hastings Center and an editor of the special report.

In addition to Kaebnick, the special report was edited by Lauren A. Taylor, an assistant professor at the New York University Grossman School of Medicine and a Hastings Center senior advisor, and Mildred Z. Solomon, president emerita of The Hastings Center.

The special report is the product of a collaboration between The Hastings Center and the American Board of Internal Medicine Foundation Building Trust initiative, with support from The Gil Omenn and Martha Darling Fund for Trusted and Trustworthy Scientific Innovation and by the ABIM Foundation. 

 

Blinking on a quiz show offers clues to human response under stress


Footage from the British TV show "Mastermind" gave University of Arizona psychologists a chance to examine human physiology under conditions of stress that would be impossible to reproduce in the lab

Peer-Reviewed Publication

UNIVERSITY OF ARIZONA




Quiz shows, where contestants answer rapid-fire questions in a high-stress, high-stakes environment, are an integral part of TV programming – and now they are demonstrating that they have research value.

By analyzing contestants' behavior and patterns of blinking on the British TV show "Mastermind," cognitive scientists at the University of Arizona have studied human physiology under conditions of stress that would be impossible to reproduce in the lab.

The results were published yesterday in the journal Psychophysiology.

"This is a dream I've had for a long time – to try to get physiological information out of video signals," said Robert Wilson, senior author on the paper, who is an associate professor in cognition and neural systems at the UArizona Department of Psychology, in the College of Science.

On "Mastermind," contestants sit in a big leather chair, Wilson said, answering rapid-fire questions under the glare of spotlights as a camera slowly zooms in on their face. The bright lights and slow camera work make it easy to identify blinks, and the stress of being interrogated on national TV cannot be re-created under lab conditions, he said.

"This is a feasible method for doing video-based neuroscience in outside-the-lab conditions so that we can get into situations that are closer to real-world scenarios," said Skyler Wyly, the lead author of the study, who began this work as an undergraduate at UArizona and is now a doctoral student at Duke University.

How blinking is related to cognitive effort still needs to be explored, especially in real world tasks, Wilson said. However, he mentioned that there is a hypothesis that the more stressed humans are, the more they blink.

"We are yet to know about all the cognitive processes that modulate blinking," Wilson said.

The researchers analyzed 25 episodes from two seasons of the game show to collect data from 100 contestants. A team of nearly 60 research assistants marked the onset and offset of every question and every response made by the contestants, as well as the time of every blink, all of which contributed to nearly 100,000 data points. The researchers then analyzed the data to determine how blinking varied across individuals at different points in the game and compared their findings to those from less-stressful experiments performed in previous lab-based studies.

One key finding from the lab is that blinking acts like a "punctuation of thought," Wilson said, and this result held true on TV. Contestants blinked at the "punctuation marks" of the game – at the start of each question and at the start of their response. They also reduced their blinking while they were thinking about how to answer, which is also in line with results from the lab, Wilson said. The stress of "Mastermind" was also apparent in contestants' blinking, with their blink rate nearly twice the number of the usual 20 blinks per minute of a person who is at rest.

However, some findings differed from lab tests. For example, in the TV show, older adults blinked more than younger adults, and women blinked more than men. In the lab, there are no differences between these groups, Wilson said.

There were also some behavioral differences. In lab tests, people tend to slow down and respond more carefully and accurately after they make an error. In "Mastermind," this was not the case.

It's not clear what is driving these differences between the lab and TV, but according to Wilson, the differences are the most exciting part of the research. One of the biggest questions in psychology right now, Wilson said, is how much of what is observed in the lab relates to what is going on in the real world.

"This question is critical, not only for our basic understanding of the mind, but also more practically if we want to find lab tests that can diagnose mental illness," Wilson said.

For the researchers at UArizona, blinks are just the beginning, and there is so much information in video signals, Wilson said. The way people look, breathe and fidget in their seat can be pulled out by modern computer vision techniques. This can help researchers get a multidimensional measure of physiology.

"This is exactly what we need to study – the psychophysiology of real human behavior and real human thinking," Wilson said.

 

Study: Temperature variability reduces nesting success


Nestlings are the most vulnerable to temperature extremes


Peer-Reviewed Publication

CORNELL UNIVERSITY

Snowy nest 

IMAGE: 

HORNED LARK NEST DURING A COLD SNAP.

view more 

CREDIT: DEVIN R. DE ZWAAN




Ithaca, N.Y.—Many songbirds are nesting earlier in spring because of warmer temperatures brought about by climate change. But the shift brings another danger that is especially deadly for nestlings: greater exposure to temperature variability in the form of cold snaps and heat waves. Such extremes result in more nest failures. These findings come from a Cornell Lab of Ornithology study just published in the journal Nature Communications.
 
"When we talk about temperature changes, the focus is mostly on averages," said co-lead author Conor Taff, a researcher in Cornell University's Ecology and Evolutionary Biology Department. "But all creatures, including humans, interact with weather conditions right in the moment, not with long-term averages. Even a one or two-day period when it’s really cold or really hot can be incredibly challenging even if the average temperature hasn't changed. Changing temperature averages and temperature variability are two different components of climate change."
 
To understand how temperature variability might affect nesting success, the researchers analyzed 300,000 breeding bird records submitted to the Cornell Lab's NestWatch project between 1995 and 2020. They pinpointed the coldest three-day day period and the hottest three-day period for each one of the nests and then looked at whether those values predicted lower nesting success. Success was measured by how many nestlings survived to fledge.
 
"We found that 16 of the 24 species we studied had reduced reproductive success when a cold snap occurred during the incubation or nestling stages," Taff said. "Eleven of 24 had reduced success when a heat wave occurred during the breeding season. Aerial insectivores were the most sensitive to temperature extremes, especially cold."

The vast majority of birds feed insects to their young, regardless of their final diet, and cold snaps reduce insect availability. If these episodes occur when nestlings are most vulnerable, they can trigger a mass die-off. During a cold snap, adult birds may move away to find survivable conditions which leaves eggs and nestlings exposed to cold and lack of food.
 
"It's the nestlings that really get hit hard because they can't regulate their own body temperature yet," said co-author Ryan Shipley, a Cornell University Ph.D. student at the time of the research. "Nestlings also grow at an exponential rate during the first week or two of life and if insect activity drops because of a cold snap, the young birds likely won’t survive."
 
Taff and Shipley also examined 100 years of weather data to see if there have been changes in the timing of cold snaps and heat waves during the March through August breeding season in the United States and Canada. Although they found no clear pattern in the timing of temperature extremes, they do note that it's getting warmer everywhere.
 
"Even if nestlings somehow manage to survive a cold snap or heat wave, there may still be long-term consequences affecting the overall health of the birds," notes Shipley. "We're only looking at a brief snapshot during early life and cannot measure long-term health in an unbanded wild population."
 
Previous Tree Swallow studies by these authors have shown that temperature during development is important because it's directly linked to the rate of nestling growth and their body mass when they fledge. That, in turn, influences how likely they are to survive, make it through migration, and return to breed the following year. Therefore, changes in the variability and timing of temperature extremes and shifts in the breeding season can combine to bring about life-changing consequences for individuals and for bird populations.


Eastern Bluebird feeding chicks.

CREDIT

Nancy Miller, courtesy Cornell Lab of Ornithology.

Tree Swallow feeding insects to chick.

CREDIT

Brian E. Kushner, courtesy Cornell Lab of Ornithology.

Reference:
Conor C. Taff and J. Ryan Shipley. Inconsistent shifts in warming and temperature variability negatively impact avian fitness. Nature Communications. November 2023. https://doi.org/10.1038/s41467-023-43071-y

 

 

Breakthrough in bladder cancer research


Peer-Reviewed Publication

NETHERLANDS CANCER INSTITUTE





After 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approach using immunotherapy combinations. The results of not just one, but two studies have been presented at the European Society for Medical Oncology (ESMO) conference in Madrid. The outcomes of these studies are going to revolutionize the landscape of bladder cancer treatment.

Traditionally, cisplatin-based chemotherapy has been the standard treatment for bladder cancer patients who are able to tolerate this drug. However, responses have been limited, and durable outcomes rare. Over the past years, two phase-3 clinical trials studied the effects of combining immunotherapy with either chemotherapy or a new drug, enfortumab vedotin, to treat bladder cancer (more exact: urothelial carcinoma). With success, both studies show a significant increase in both overall survival as well as progression-free survival.

Medical oncologist Michiel van der Heijden from the Netherlands Cancer Institute (NKI) explains: “these results mark a milestone in bladder cancer research, providing the first evidence of a survival benefit of combination therapy involving immune checkpoint inhibitors over chemotherapy. This is an exciting development in our field, as these findings will thoroughly change the treatment landscape for advanced bladder cancer. It is a testament to the collaborative efforts of researchers, and most importantly, the resilience of all patients who participated in this study."

Combining therapies

The CheckMate 901 trial investigated a new combination of the drugs nivolumab and gemcitabine-cisplatin and compared this to treatment with only chemotherapy. The results demonstrated that patients treated with both drugs showed a 22% reduction in the risk of death compared to patients only treated with chemotherapy. The findings also showed that the combination of nivolumab and chemotherapy led to a significant improvement in progression-free survival vs chemotherapy alone.

The results will be published in the esteemed New England Journal of Medicine at the same time as the presentation at ESMO. 

During this ESMO presidential session, the results of another phase-3 in the same treatment line will be presented, featuring a novel combination of an antibody-drug conjugate with immune checkpoint inhibition, using Enfortumab Vedotin + pembrolizumab. This study found a statistically significant and clinically meaningful improvement in overall survival and progression-free survival as well. These results will be published in a scientific journal at a later time.

Both treatments are yet to be registered and approved in the Netherlands for  health insurance coverage, meaning that they will not yet be readily available. In the US, the Enfortumab Vedotin + pembrolizumab is already available for a subgroup of bladder cancer patients, based on a phase 2 study.

Unique

Michiel van der Heijden is involved in both these trials, making it a special occasion for the NKI to have such a leading role in two large studies that can change clinical practice. “It is very special to give a presidential lecture during ESMO. I have not had this honor before and it may very well not happen again anytime soon. Last year was a very special occasion as well, as two NKI researchers, Myriam Chalabi and John Haanen, both presented their findings in the presidential session. Not many researchers have received this honor, making this a really unique moment for the NKI once again.”

IVI signs MOU with University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to establish the Hong Kong Jockey Club Global Health Institute


Business Announcement

INTERNATIONAL VACCINE INSTITUTE

HKJC Global Health Institute MOU Signing Ceremony 

IMAGE: 

WITNESSED BY THE SECRETARY FOR HEALTH OF THE HKSAR GOVERNMENT PROFESSOR LO CHUNG-MAU (BACK ROW, CENTER); CLUB CHAIRMAN MICHAEL LEE (BACK ROW, 2ND RIGHT); PRO-CHANCELLOR OF HKU AND FOUNDING CHAIRMAN OF THE FRIENDS OF CAMBRIDGE UNIVERSITY IN HONG KONG DR THE HON SIR DAVID LI (BACK ROW, 1ST RIGHT); THE CHAIRMAN OF THE COUNCIL OF HKU PRISCILLA WONG (BACK ROW, 2ND LEFT); AND THE CHAIRPERSON OF THE BOARD OF TRUSTEES OF THE IVI GEORGE BICKERSTAFF (BACK ROW, 1ST LEFT), THE MOU WAS SIGNED BY CLUB CEO WINFRIED ENGELBRECHT-BRESGES (FRONT ROW, 2ND RIGHT); THE PRESIDENT AND VICE-CHANCELLOR OF HKU PROFESSOR XIANG ZHANG (FRONT ROW, 2ND LEFT); REGIUS PROFESSOR OF PHYSIC AND HEAD OF THE SCHOOL OF CLINICAL MEDICINE OF THE UNIVERSITY OF CAMBRIDGE PROFESSOR PATRICK MAXWELL (FRONT ROW, 1ST RIGHT) AND THE DIRECTOR GENERAL OF THE IVI DR JEROME KIM (FRONT ROW, 1ST LEFT).

view more 

CREDIT: HKJC




November 16, 2023, Republic of Korea  — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, signed an MOU yesterday with University of Cambridge (UCAM), University of Hong Kong (HKU), and the Hong Kong Jockey Club (HKJC) to promote vaccine research and global health initiatives, including the establishment of the Hong Kong Jockey Club Global Health Institute (HKJCGHI).

 

HKJC will support the HKJCGHI through one of their largest donations in history, aiming to advance vaccine research and development, particularly for pathogens of pandemic potential, while offering a robust training and education program for post-graduate students and future public health leaders. Leveraging their respective strengths, the founding partners seek to establish a center specialized in vaccine process and platform development, epidemiology, immunology, health economics, and capacity-building.

 

With a commitment to strengthening pandemic preparedness and regional prevention and control of infectious diseases, HKJCGHI will bring the latest translational vaccine technology to Hong Kong and bolster local and regional vaccine industries.

 

George Bickerstaff, Chairperson of IVI’s Board of Trustees, said: “We are incredibly excited to join forces with the University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to create a vital new hub for vaccine science and education. The founding of the Hong Kong Jockey Club Global Health Institute is an exemplar of positive partnership between research, academia, and philanthropy coming together for public good. IVI is grateful to the Hong Kong Jockey Club for the support and opportunity to take part in this essential effort.”

 

Michael Lee, Chairman of HKJC, said: “Hosted by the University of Hong Kong, the Hong Kong Jockey Club Global Health Institute will bring world-leading scientists and research teams from the International Vaccine Institute and the University of Cambridge to Hong Kong to work on translational vaccine research. With vaccines being the most powerful means of disease control, we want it to become a platform for fostering collaboration and cross-pollination of cutting-edge technologies.”

 

Dr. Jerome Kim, Director General of IVI, said: “IVI is proud to collaborate with the University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to create a global center at the cutting edge of vaccine R&D and training. With an emphasis on translational research, public-private partnership, and capacity-building, HKJCGHI aims to advance the access and affordability of critical vaccine technologies ahead of future pandemics. We look forward to integrating the institute into the broader global health ecosystem.”

 

The MOU signing ceremony took place on the campus of HKU with the signatures of Mr. Winfried Engelbrecht-Bresges, CEO, HKJC; Prof. Xiang Zhang, President and Vice-Chancellor, HKU; Prof. Patrick Maxwell, Regius Professor of Physics and Head of School, School of Clinical Medicine, UCAM; and Dr. Jerome H. Kim, Director General, IVI.

 

Mr. George Bickerstaff, Chairperson of IVI’s Board of Trustees, attended the ceremony as well as Ms. Lily Li, IVI Board Member and CEO and Founder of Harvard Wealth Strategy and Management, and Dr. Florian Marks, Deputy Director General of Epidemiology, Public Health, and Impact at IVI.

 

 

###

 

 

About the International Vaccine Institute (IVI)

The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO), and developed a new-generation typhoid conjugate vaccine that is currently under assessment for WHO PQ.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int

 

High levels of maternal stress during pregnancy linked to children’s behavior problems


Pregnancy a critical time for mental health care and support, study suggests


Peer-Reviewed Publication

AMERICAN PSYCHOLOGICAL ASSOCIATION




WASHINGTON – Children whose mothers are highly stressed, anxious or depressed during pregnancy may be at higher risk for mental health and behavior issues during their childhood and teen years, according to research published by the American Psychological Association.

“Our research suggests that psychological distress during the pregnancy period has a small but persistent effect on children’s risk for aggressive, disinhibited and impulsive behaviors,” said study author Irene Tung, PhD, of California State University Dominguez Hills. “These findings add to the evidence that providing widely accessible mental health care and support during pregnancy may be a critical step to help prevent childhood behavior problems.”

Tung and her colleagues analyzed data from 55 studies with more than 45,000 total participants. All the studies measured women’s psychological distress during pregnancy (including stress, depression or anxiety) and then later measured their children’s “externalizing behaviors” -- mental health symptoms directed outward, such as attention deficit hyperactivity disorder or aggression. 

Overall, the researchers found that women who reported more anxiety, depression or stress while pregnant were more likely to have children with more ADHD symptoms or who exhibited more difficulties with aggressive or hostile behavior, as reported by parents or teachers.

The research was published in the journal Psychological Bulletin.

Research has long suggested a link between mothers’ mental health during pregnancy and children’s externalizing behaviors. However, many previous studies have not disentangled the effects of stress, anxiety or depression during pregnancy from the effects of parents’ psychological distress after a child is born.

In the current study, the researchers only included research in which mothers’ psychological distress was measured both during and after pregnancy. They found that even after controlling for later (postnatal) psychological distress, distress during pregnancy in particular increased children’s risk of developing externalizing problems.

The effect held true regardless of whether the children were boys or girls. And it held true for children in early childhood (ages 2-5), middle childhood (6-12) and adolescence (13-18), though the effect was strongest in early childhood.

The findings are consistent with theories that suggest that exposure to stress hormones in utero can affect children’s brain development, according to the researchers.

Future research should focus on increasing diversity to understand the cultural and socioeconomic variables that affect prenatal stress and to develop effective interventions, according to Tung.

“Most existing research has focused on white, middle-class and higher educated samples. But experiences of racism, economic disparities and lack of health care access are known contributors to stress during pregnancy. Understanding how psychological distress during pregnancy impacts underrepresented families is key to developing equitable public health policies and interventions,” she said. 

She and her colleagues are now conducting two studies focused on understanding the types of support and resources that promote resilience and recovery from stress during pregnancy, particularly for families facing health inequities. The goal is to help inform culturally inclusive preventive interventions during pregnancy to help support early mental health resilience and well-being for parents and their children.   

Article: “Prenatal Stress and Externalizing Behaviors in Childhood and Adolescence: A Systematic Review and Meta-analysis,” by Irene Tung, PhD, California State University Dominguez Hills; Alison E. Hipwell, PhD, University of Pittsburgh School of Medicine; Philip Grosse, MS, and Jill E. Foust, MLS, University of Pittsburgh; and Lindsey Battaglia, Elena Cannova, Gabrielle English, Allysa D. Quick, Bianca Llamas, and Megan Taylor, MS, University of Pittsburgh Medical Center. Psychological Bulletin, published online November 16, 2023.

CONTACT: Irene Tung can be reached at itungphan@csudh.edu

The American Psychological Association, in Washington, D.C., is the largest scientific and professional organization representing psychology in the United States. APA’s membership includes over 146,000 researchers, educators, clinicians, consultants and students. Through its divisions in 54 subfields of psychology and affiliations with 60 state, territorial and Canadian provincial associations, APA works to advance the creation, communication and application of psychological knowledge to benefit society and improve people’s lives.